Printer Friendly

Influence of the Fermented Feed and Vaccination and Their Interaction on Parameters of Large White/Norwegian Landrace Piglets.

1. Introduction

The challenges associated with livestock production become greater each year. This phenomenon is associated with population growth, as well as growing needs for animal-based products. Farms have become bigger, and animals are always exposed to opportunistic and pathogenic microorganisms. Most pathogen infections have a multifunctional influence on the host tissues and cells, and the response to the infection rather than the infection itself results in most of the damage and a general disturbance in physiological processes [1-5]. One consequence of infections on pig production is multi-systemic wasting syndrome after weaning. Indeed, it is crucial to ensure piglets health at the earliest stage, because type 2 porcine circovirus (PCV2) leads to multi-systemic wasting syndrome after weaning, and co-infection with other pathogens can be lethal [6,7]. Some published findings have indicated the potential participation of PPV2 in clinical diseases. PCV2 can occur as a co-infection with other pathogens in animals afflicted with respiratory disease [8], as well as in the lungs of animals with inflammatory lesions [9]. PCV2 infection leads to metabolic and neurological disorders; the latter cause multi-systemic wasting syndrome [10-12], To improve animal keeping conditions, understanding the interactions between desirable microorganisms and pathogens and reduce the risk of secondary infections is critical to develop preventive measures against various diseases. In this study, we hypothesised that, for vaccinated piglets, incorporating antimicrobial strains for feed fermentation can be a very attractive feeding option. Finally, incorporation and bio-modification of local feedstock with antimicrobial lactic acid bacteria (LAB) strains can lead to higher value feedstock for farm animal nutrition and improve their conditions. This use can also increase the sustainability of pig farming and reduce dependence on imported soya stock. In this case, natural antimicrobial treatment, e.g., feed fermentation with antimicrobial LAB strains, is also desirable because the genetic diversity of PCV2 continuously increases, and novel subtypes are still emerging [13-15]. PCV2-related diseases are considered multifactorial in the swine industry [7], and they can promote co-infection with other viruses or bacteria [8,9,16]. In addition, co-infection of different viruses complicates the infection status and makes it more difficult to prevent and control the diseases [17]. Vaccines are used to prevent viral infections and antibiotics are used to treat bacterial diseases, but there is a lack of complex tools for prevention of diseases. Furthermore, viruses and bacteria can mutate very quickly, a phenomenon that remains a huge challenge for the livestock industry. Animals are always exposed to the environment, and thus changes in the microorganisms present in digestive tract should be studied to understand the mechanism of action, which can be associated with vaccination, as well as with the natural antimicrobials, as the microorganisms in the gut strongly influence the immune system and animals' health.

The aim of this study was to evaluate the influence of fermented with a newly isolated LAB strains combination (Lactobacillus plantarum LUHS122, Lactobacillus casei LUHS210, Lactobacillus farraginis LUHS206, Pediococcus acidilactici LUHS29, Lactobacillus plantarum LUHS135 and Lactobacillus uvarum LUHS245) feed on non-vaccinated (NV) and vaccinated with Circovac porcine circovirus type 2 vaccine (QI09AA07, CEVA-PHYLAXIA Co. Ltd. Szallas u. 5. 1107 Budapest, Hungary) piglets' blood parameters, gut microbial composition, growth performance and ammonia emission. This LAB starter combination, with antimicrobial characteristics, was used to ferment local feed stock (rapeseed meal), and the influence of changing from an extruded soya to bio-modified rapeseed meal on the parameters of non-vaccinated piglets and those vaccinated with the Circovac PCV2 vaccine was evaluated.

2. Materials and Methods

2.1. LAB Strains Used for Feed Fermentation, Feed Fermentation and Fermented Feed Parameters

The L. plantarum LUHS122, L. casei LUHS210, L. farraginis LUHS206, P. acidilactici LUHS29, L. plantarum LUHS135 and L. uvarum LUHS245 strains were obtained from the Lithuanian University of Health Sciences collection (Kaunas, Lithuania). Our previous studies showed that the above-mentioned strains inhibit various pathogenic and opportunistic microorganisms and are suitable for fermentation of various cereal substrates [18-22], as well for rapeseed meal fermentation [23]. The rapeseed meal, water and LAB strains (equal parts of each strain by volume) suspension (3% from dry matter of feed mass, v/m), containing 8.9 logio colony forming units CFU/mL, was fermented at 30 [+ or -] 2 [degrees]C for 12 h. The fermentation process involves wheat and rapeseed meal (1:1 ratio). The crude protein content of the rapeseed meal was 33.58%. Fermented feed was composed of 25% fermented rapeseed meal and 25% fermented wheat. This combination contained 23.24% crude protein. The compound feed for all groups contained 19% crude protein, crude fibre--3.15%, crude oil-- 6.51%, lysine--1.45%, methionine--0.55%, tryptophan--0.26%, threonine--0.93%, Ca--0.90%, total P-- 0.59% and Na--0.20%. The entire fermented wheat/rapeseed meal mass was divided in two parts: 70% (by mass) was used for piglet feeding, and 30% (by mass) was used as a starter for additional feed fermentation cycles (Figure 1). The detailed fermented feed technology and characteristics are described by Vadopalas et al. [23].

2.2. Animals and Housing

All animal procedures were conducted according to the European Union (EU) Directive of the European Parliament and Council, from 22 September, 2010 [24], on the protection of animals used for scientific purposes and the 'Requirements for the Keeping, Maintenance and Use of Animals Intended for Science and Education Purposes', approved by the order of the Lithuanian Director of the State Food and Veterinary Service [25]. The study was conducted at a pig farm in the Klaipeda district (Kontvainiai, Lithuania) and at the Institute of Animal Rearing Technologies, Lithuanian University of Health Sciences (Kaunas, Lithuania). A 36-day experiment was conducted using 25- day-old Large White/Norwegian Landrace (LW/NL) piglets with an initial body weight of 6.9-7.0 kg. Four groups were formed, each with 100 piglets: [S.sub.nonV]--non-vaccinated piglets fed with control group compound feed; Sy--vaccinated piglets fed with control group compound feed; [RF.sub.nonV]--non-vaccinated piglets fed with fermented compound feed; [RF.sub.v]--vaccinated piglets fed with fermented compound feed. The weaner piglets were kept at the same conditions in a section with two climate zones. The first had a heated concrete floor (36 [degrees]C) and roof on it; the second had plastic piglet floors and optimum ventilated air and temperature for the active period. Drinking water and compound liquid feed were available ad libitum throughout the trial. Antibiotic treatment was not applied.

2.3. Experimental Design and Diets

Samples from 10 animals per group were collected at the beginning and end of experiment. Two groups ([S.sub.v] and [RF.sub.V]) were vaccinated by intramuscular injection with Circovac PCV2 vaccine (inactivated) (QI09AA07, CEVA-PHYLAXIA Co. Ltd. Szallas u. 5. 1107 Budapest, Hungary), which is used to protect pigs against PCV2. The influence of two dietary treatments on vaccinated and non-vaccinated piglets' parameters were compared. Fermented feed, comprising 500 g/kg of total feed, was included in the diet of treated group beginning at day 25 of life until day 61. Piglets' growth performance was evaluated by testing all 100 piglets in each group. The basal feed was formulated according to the nutritional requirements prescribed in the Nutrient Requirements of Swine [26]. The feed composition and nutritional value are shown in Table 1. The nutritional value of compound feed was determined according to the analytic methods described by Association of Official Analytical Chemists (AOAC) [27],

2.4. Meta-genomics and Microbial Profiling Analysis

Before the experiment, faeces from 25-day old piglets from each group (10 piglets per group) were collected. The same procedure, using 10 piglets per group, was performed at the end of the experiment (day 61 of the piglets' life). Faecal samples from each of the group were pooled making 4 samples before and 4 samples after the experiment. Therefore, 8 samples representing 4 tested groups (before and after the experiment) were sequenced for microbial profiling. Specimens were kept in DNA/RNA Shield diluted 1:10 (R1100-250, Zymo Research, Irvine, CA USA) at -80 [degrees]C before DNA extraction. DNA was extracted with a faecal DNA MiniPrep kit (D6010, Zymo Research, Irvine, CA USA). Library preparation, meta-genomic sequencing and taxonomic characterisation of reads was performed as previously described [28]. ZymoBIOMICS Microbial Community Standard (D6300, Zymo Research, Irvine, CA USA) was used as a micro-biome profiling quality control. The results of taxonomic classification were visualised using the interactive online platform https://genome-explorer.com.

2.5. Microbiological Analysis of Faecal Samples

Piglets' faecal samples were collected before and after the experiment, stored in vials (+4 [degrees]C) with a transport medium (Faecal Enteric Plus, Oxoid, Basingstoke, UK) and analysed on the same day. Evaluation of the microbiological parameters (LAB, total viable bacteria count [TVC], total enterobacteria count [TEC], and yeast and mould [Y/M] counts) was performed according to methods described by Zavistanaviciute et al. [29].

2.6. Blood Analysis

Piglets were bled from the jugular vein into vacuum blood tubes (BD Vacutainer, Wokingham, UK) before morning feeding. Tubes with clot activator were used for biochemical examination. Blood biochemical variables were evaluated before and after the experiment (on days 25 and 61 of the piglets' life). The parameters included aspartate aminotransferase (AST), alanine aminotransferase (ALT), cholesterol (Choi), high density lipoprotein cholesterol (HDL-C), low- density lipoprotein cholesterol (LDL-C), triglycerides (TG), total protein (TP), albumin (ALB), phosphorus (IP), Mg, K, Na, triiodothyronine (T3), thyroxine (T4), immunoglobulin G (IgG), vitamin B12, albumin (ALB), Fe, glucose (GLU), Ca, creatinine analysed by the Jaffe method (CREA), alkaline phosphatase (AP), thyroid-stimulating hormone (TSH), total bilirubin and urea. Blood parameters were analysed with an automatic biochemistry analyser in the accredited laboratory 'Anteja' (Klaipeda, Lithuania).

2.7. Evaluation of Piglets' Growth Performance and Cases of Mortality and Diarrhoea

Group body weight gain (BWG) was recorded on days 25, 32, 39, 46, 53, and 61 of age using an electronic weighing system (model type: IT1000, SysTec GmbH, Bergheim, Germany) and average daily gain (ADG) was calculated. The feed conversion ratio (FCR) was calculated from feed intake (87% of dry matter) and body weight gain (BWG). Feed consumption was measured using a WEDA (Dammann & Westerkamp GmbH, Goldenstedt, Germany) automated feeding system that has an electronic flowmeter and weighing system. Cases of mortality and diarrhoea were recorded in all tested groups throughout the experiment.

2.8. Analysis of Ammonia Emission

Analysis of ammonia emission was conducted according to the Environmental Protection Document LAND 88-2009 method, approved by the Nr. Dl-862 order (31 December, 2009) of the Lithuanian Minister of Environment [30]. Ammonia concentration in the air was analysed by the accredited laboratory "Labtesta" (Kretinga, Lithuania). Air samples were taken on the first and the last day of experiment in four tested farm sectors: [S.sub.nonV], [S.sub.v], [RF.sub.n0nV], and RFV.

2.9. Statistical Analysis

Data were subjected to multivariate analysis of variance (ANOVA) using the statistical package SPSS for Windows (Ver.15.0, SPSS, Chicago, IL, USA). Baseline measurements were used as covariates to consider the experimental conditions. The mean values were compared using Duncan's multiple range test with a significance level defined at p [less than or equal to] 0.05. In order to evaluate the influence of three different factors (piglets age related differences, the use of fermented feed, vaccination) and their interaction on piglets' parameters, data were subjected to three-way ANOVA and the post hoc Tukey honest significant difference (HSD) test. In the tables, the results are presented as mean values (n = 10). Differences in bacterial genera between the groups at the end of the experiment were assessed using the Z-Test Calculator for two Population Proportions (Social Science Statistics, socscistatistics.com, 2019). The results were considered statistically significant at p [less than or equal to] 0.05.

3. Results and Discussion

3.1. Microbial Profiles of Pig Faeces

The number of bacterial reads in pig faeces before and after the experiment was quite similar: it varied between 35,000 and 40,000 reads among the groups. The number of species with a prevalence of at least 0.01% from the total amount of bacteria in different groups before the experiment was also similar: it varied from 400 in the [RF.sub.n0nV] group to 473 in the [S.sub.V] group. The number of species with the same prevalence rate at the end of experiment varied from 340 to 387. Although the number of bacterial reads and bacterial composition among the groups was similar, we detected some distinct differences, particularly in the number of lactobacilli.

Before experiment, two bacterial genera--Prevotella and Lactobacillus, had the highest prevalence rates in all groups of pigs; they accounted for more than 40% of the total amount of bacterial composition (Figure 2). The prevalence of Prevotella varied from 21.8% to 38.2%, while Lactobacillus prevalence ranged from 19.9% to 29.7%. The lowest Lactobacillus prevalence was in the RFV group, while the highest was in Snonv group. In all groups, the most prevalent species among Lactobacillus was Lactobacillus amylovorus (Tables S1-S4)). The other most prevalent genera included Barnesiella, Clostridium, Blautia, Faecalibacterium, Roseburia and Eubacterium, which ranged from 1.2% (Eubacterium) up to 3.4% (Barnesiella) in the faeces. Overall, the microbial profiles were similar among all the groups before the experiment (Figure 2), however, it should be mentioned that Bifidobacterium was detected only in two groups--RFnonV and RFV with the prevalence of 4.5% and 1.7% respectively.

At the end of experiment, the microbial profiles had changed depending on the pig group (Figure 3). Overall, the main genera remained similar as before experiment, but there were obvious differences in the Lactobacillus prevalence. The lowest prevalence occurred in faeces from the Snonv group, while the highest was in the RFV group (p [less than or equal to] 0.05). In the latter group, lactobacilli were the most abundant bacteria: their prevalence reached 47.9% of the total bacteria, while in the rest of the groups the highest prevalence was Prevotella. When comparing groups with fermented vs. non-fermented feed, pigs that received fermented feed had a notably higher Lactobacillus prevalence compared to pigs fed non-fermented feed. The pigs from non-fermented feed groups had higher Clostridium and Terrisporobacter prevalence (p [less than or equal to] 0.05), while the prevalence of other bacterial genera was low overall in all groups.

When comparing non-vaccinated with vaccinated groups, the main differences were also associated with the Lactobacillus prevalence: it was higher in vaccinated compared to non- vaccinated groups (p [lss than or equal to] 0.05). At the same time, the amount of Prevotella was higher in non-vaccinated groups, although the differences between [RF.sub.nonV] and [S.sub.nonV] groups were small (31.4% vs. 30.2%). The species prevalence and variety at the end of the experiment are presented in Tables S5-S8).

The microbial communities in the pig gut perform a variety of beneficial functions [31]. Previous studies of the gut microbial community have illustrated how populations of constituents are shaped by environmental exposure to microbes, diet, immunological pressures, host genetics and ecological forces within the ecosystem itself [32-34], Understanding which microbial populations are influenced by fermented feed provides insight into how dietary changes in pigs shape the gut micro-biome. Although there have been studies about microbial communities within the gut of healthy pigs, the microbial composition can differ depending on breed, age, place, feed, hygiene conditions and other factors [31,35,36]. This study demonstrated changes in microbial profiles using feed prepared by different technologies within similar groups of animals and the same farm. While the exact mechanism(s) by which vaccination can influence microbial changes within the gut of mammals remains unknown, this study suggests that vaccination has a certain influence, particularly on the number of Lactobacillus spp.

Before the experiment, the microbial composition in all groups was very similar, with the highest prevalence for Prevotella and Lactobacillus, both of which accounted for 56% of the bacterial count. These genera include abundant microorganisms in young weaned healthy pigs [37], Prevotella spp. are usually dominant in pigs' gut and gradually increase in number with age [38,39]. Prevotella spp. are key microbial members of the gastrointestinal tracts of adult animals; they are crucial for the degradation of starch and plant polysaccharides but also have a strong capacity for mucoprotein catabolism [40,41], Lactobacillus spp. are common in both the proximal and distal regions of the porcine digestive tract; they colonise soon after birth [42], This genus influences intestinal physiology, regulates the immune system and balances the intestinal ecology of the host [43]. In addition, Lactobacillus spp. have been known to metabolise carbohydrates, including oligosaccharides and starch, which are fermented in the large intestine to short chain fatty acids by lactobacilli for subsequent utilisation by the pigs [44], Previous studies have indicated that stress greatly affects the gastrointestinal micro- biota: it decreases total Lactobacillus populations and thus provides an opportunity for pathogen overgrowth [45]. Such stress usually occurs during the weaning period. According to the literature, when compared to diarrhoeic piglets, the gut microbiota of healthy piglets has a higher abundance of Prevotellaceae, Lachnospiraceae, Ruminococcaceae and Lactobacillaceae [46]. These data suggest that the gut microbial composition may be used as a biomarker to predict the health status of piglets. The present study demonstrated the positive impact of fermented feed on the porcine microbial composition compared with a conventional feeding regimen in healthy pigs. At the end of the experiment (day 61 of the piglets' life), the Lactobacillus prevalence decreased on average 2.4 fold in the groups fed non-fermented feed, whereas the prevalence increased on average 1.8 fold in the groups fed fermented feed. Hence, providing fermented feed prevents the decrease in Lactobacillus prevalence after weaning. This effect may help prevent digestive disorders associated with microbial changes because this period is one of the most critical regarding different infections [46]. It is known that during this age, Lactobacillus spp. in pigs normally decrease in number [37], The Lactobacillus prevalence was also higher in vaccinated compared with non-vaccinated groups irrespective of the feed type. However, the data do not indicate whether vaccination against PCV2 leads to an increase in Lactobacillus prevalence; more experiments are required in this area. Moreover, different types of vaccines and larger experiments should be performed to better understand the possible influence of vaccination on the microbial communities. According to this study, it may be assumed that at the very least vaccination against PCV2 does not negatively affect the microbial composition within the gastrointestinal tract of pigs.

3.2. LAB, TVC, TEC and M/Y Counts in Piglets' Faeces

Microbiological parameters of the piglet faeces (from 25- and 61-day-old piglets) are shown in Table 2 (Table S9--Differences between microbiological parameters of the piglets' faeces between all the tested groups). In most groups (except the Sy group), the LAB count was significantly lower at the end compared with the beginning of the experiment (20.1% lower in the [S.sub.nonV] group; 37.9% lower in the RFnonV group; and 25.3% lower in the [RF.sub.V]). The LAB count at the end of experiment was significantly higher in both vaccinated compared with non-vaccinated groups (26.6% for Sy and 17.2% for [RF.sub.V]). The LAB count was 26.3% higher in Sy compared to the RFy group at the end of the experiment. In a previous study, the faeces of pigs receiving a diet with fermented feed contained significantly fewer total bacteria and fungi, as well as coliform bacteria (including Escherichia coli) and anaerobic Clostridium perfringens counts. This phenomenon is due in part to the reduction in pH, an increase in the amount of lactic acid and other volatile fatty acids in the intestinal contents and a reduction in the number of Enterobacteriaceae [47,48]. From birth until weaning and then during the post-weaning period, the gut micro-biota is dynamic and undergoes major compositional changes that are driven by age, exposure to microbes, environmental conditions and diet [49]. Many authors have described the great impact of early-life events in mammals, and particularly in pigs, on their future health. These experiences shape immune system development through changes in the pattern of microbial intestinal colonisation [50,51]. Colonisation is initiated at birth and is shaped by consumption of the sow's milk, which provides nutritional advantages to the LAB population, building a milk-oriented micro-biome that includes Bacteroidaceae and Lactobacillaceae. This composition rapidly changes after weaning when a (largely) plant-based diet is introduced [35]. The rapidly varying micro-biome of young piglets seems to increase in microbial diversity and richness in the suckling phase and gradually stabilises post-weaning [35,52,53]. Our results are in agreement with Bian et al. [54], namely that members of the Lactobacillaceae became predominant on days 7,14 and 28, but had a lower relative abundance again on day 49.

When comparing the TVC in piglets' faeces, in all but the [S.sub.V] group it was significantly lower at the end of experiment compared with the beginning (9.5% reduction in the [S.sub.nonV] group; 23.6% reduction in the [RF.sub.nonV] group; 3.4% reduction in the [RF.sub.v] group). TVC was significantly higher in the vaccinated piglets compared to the non-vaccinated piglet faeces at the end of the experiment (22.2% for [S.sub.V] and 13.8% for RFy). Between the vaccinated groups, TVC was 10.0% higher in the [S.sub.V] compared to the [RF.sub.V] group. During weaning, there is gut micro-biota dysbiosis, including a loss of microbial diversity. Studies have noted significant reductions in total bacterial number, including coliform bacteria and anaerobic C. perfringens, as well as an increase in Acetivibrio, Dialister, Oribacterium, Prevotella and Proteobacteriaceae, including E. coli [48,49,55,56]. A decrease in Lactobacillus spp. can lead to decrease in TVC. Zimmerman et al. [57] demonstrated that Lactobacillus, Bifidobacterium and Lactobacillus spp. have a positive immunomodulatory effect on vaccines in animals.

In all the groups, the TEC and Y/M counts were lower in piglets' faeces at the end compared with the beginning of the experiment (11.9 and 5.5%, respectively, for the [S.sub.nonV] group; 26.1 and 44.1%, respectively, for the [S.sub.V] group; 7.2 and 7.9%, respectively, for the [RF.sub.nonV] group; 6.1 and 5.6%, respectively, for the [RF.sub.V] group). Both TEC and Y/M were significantly lower in the [S.sub.V] compared to [S.sub.nonV] group faeces at the end of experiment, but the opposite was true for the [RF.sub.V] compared to the [RF.sub.nonV] group. At the end of the experiment, the TEC and Y/M counts were higher in the [RF.sub.V] compared to the [S.sub.V] group (13.2 and 31.2%, respectively). Our results are in agreement with Dowarah et al. [58], who showed that fermented feed improved the number of beneficial microbes (LAB and bifidobacteria) and reduced E. coli and clostridia count, the pathogens responsible for diarrhoea, in faces. Arfken et al. [59] investigated the mutualistic relationship between yeast in the piglet gastrointestinal (GI) tract and Lactobacillus count. There was a significant reduction in the total number of fungi compared with the control group [48].

The ANOVA results indicated that there were significant treatment duration, fermented feed and vaccination main effects, as well as significant treatment duration x fermented feed, treatment duration x vaccination, fermented feed x vaccination and treatment duration x fermented feed x vaccination interactions on microbiological parameters of the pig faeces. Indeed, only the fermented feed x vaccination interaction was not significant for TVC in pig faeces.

Finally, microbiological parameters of the piglets' faeces were varied and, in most of the cases, influenced by the analysed factors and their interaction. Considering that genera and species as well as the interaction between strains can lead changes of piglets' growth performance, correlation between the above-mentioned parameters were calculated.

3.3. Piglet Blood Parameters

The piglets' blood parameters are shown in Table 3 (Table S10--Differences between blood parameters of the piglets' between all the tested groups). At the end of experiment, there were significantly lower ALT, T3, T4, IP, Mg, K, Ca and vitamin B12 concentrations in the [S.sub.V] compared with the [S.sub.nonV] group. However, in the [S.sub.V] group, Choi, HDL-C, TP and GLU concentrations were significantly higher compared with the SnonV group. At the end of experiment, there were significantly lower ALT, HDL-C, LDL-C, TP, ALB and Fe blood concentrations in the [RF.sub.V] compared to [RF.sub.n0nV] group. However, in the [RF.sub.V] group blood, TG and total bilirubin concentrations were significantly higher compared with the [RF.sub.nonV] group.

When comparing blood parameters between the vaccinated groups ([S.sub.V] and [RF.sub.V]) at the end of experiment, ALT, TG, IgG, Mg, K, Fe and total bilirubin were significantly higher in the [RF.sub.V] group. By contrast, HDL-C, LDL-C, TP, ALB, T3, T4 and vitamin B12 were significantly lower in the [RF.sub.V] compared with the [S.sub.V] group.

In general, blood biochemical indices reflect comprehensive functions of piglet's nutritional metabolism, health and welfare [60]. The IgG level reflects immune status, plays important roles in the humoral immune response and controls bacterial infections in the body; it can also function to control diarrhoeal infections by binding multiple pathogenic antigens [46]. Lu et al. [59] reported that IgG and immunoglobulin M (IgM) concentrations were significantly greater and serum ALT and AST concentrations were decreased in pigs that received fermented feed (p [less than or equal to] 0.05). The activities of the hepatic enzymes ALT and AST are key indices that reflect the acute injury of liver. The ALT blood concentration increases when the liver cell membrane is damaged. The AST content significantly increases when the liver

mitochondrial membrane is impaired [60]. The blood TP concentration reflects the relationship between protein absorption in vivo and humoral immunity [60]. The hydrolysis products of glucosinolates are known to depress iodine metabolism in the thyroid gland and inhibit the synthesis of thyroid hormones T3 and T4. When these compounds, especially thiocyanates, interfere with iodine uptake, hypothyroidism and thyroid gland enlargement may ensue [46]. However, in this study the utilised rapeseed meal contained very low concentrations of erucic acid and glucosinolates (7.5-11.2 [micro]mol/g). Hence, the influence of the above-mentioned compounds on T3 and T4 should be minimal. The fermentation process can reduce dietary anti-nutrients (phytates, glucosinolates and trypsin inhibitors) and improve the absorption and use of nutrients, including amino acids and minerals (e.g., P, Ca, Zn, Cu and Fe) [48,61]. These changes can lead to haematological, biochemical and mineral profile variations in the blood [61,62], However, it was published that the TP concentration was increased in the blood of piglets fed fermented feed [63]. In opposition to above-mentioned findings, Min [64] reported that the TP blood concentration was not affected by the fermented feed diets. In serum samples from piglets fed with fermented feed, there were higher ALP, TP, ALB and GLU concentrations [62,65,66]. Liu et al. [15] published that piglets fed fermented feed had lower levels of serum IgG, but there was no difference in the immunoglobulin IgA and IgM serum levels. Furthermore, the serum glucose level was decreased in piglets fed fermented feed; however, TP, Choi, TG, LDL-C, ALT, AST, Ca, P and Mg were not different among the treatments [67], Satessa et al. [68] found that fermented rapeseed meal reduced the glucose, HDL-C and LDL-C concentrations, but TP, P, AST, ALT concentrations were increased, and significant changes in blood IgG were not established. According to Czech et al. [61], the blood concentrations of Choi and TG AST in piglets fed with fermented rapeseed meal was reduced, and there was better availability of minerals.

The influence of the analysed factors and their interaction on piglets' blood parameters is shown in Table 4. Vaccination as a separate factor did not significantly influence piglets' blood parameters. However, the treatment duration x fermented feed interaction was significant for T3 (p = 0.038), T4 (p = 0.041) and Fe (p = 0.008) concentrations in piglets' blood. There was a significant treatment duration x vaccination interaction on T4 (p = 0.008) and K (p = 0.007) concentrations in piglets' blood. Finally, there was a significant fermented feed x vaccination interaction for T4 (p = 0.033), vitamin B12 (p = 0.003) and urea (p = 0.014) concentrations in piglets' blood. All three factors were significant with regard to the TP content in piglets' blood (p = 0.041).

3.4. Piglets' Growth Performance

The piglets' average FCR, ADG and the influence of analysed factors and their interaction on piglets' growth performance parameters from day 25 to 61 are shown in Table 5. For ADG, there were no significant differences among the groups. In addition, the analysed factors as well as their interactions did not exert significant effects on piglets' ADG. However, there were significant differences in FCR between [S.sub.V] and Snonv (11.5% lower in the SV group), between [RF.sub.V] and [RF.sub.nonV] (10.2% lower in the [RF.sub.nonV] group) and between [S.sub.V] and RFy (21.6% lower in the [S.sub.V] group). There was a significant, very strong positive correlation between FCR and TEC in piglets' faeces (R = 0.919, p = 0.041). There were no significant correlations between the other analysed faecal microbiological parameters (LAB, TBC and Y/M count) and FCR or ADG.

Mortality and diarrhoea cases were similar in all groups throughout the experiment. The mortality of piglets in the non-vaccinated groups ([S.sub.nonV] and [RF.sub.nonV]) was 2%, while mortality in the vaccinated groups (Sy and RFV) was 2% and 3%, respectively. There was more intense diarrhoea in the [S.sub.nonV] group at day 31 and 36. There were several diarrhoea cases in the [S.sub.V], [RF.sub.nonV] and [RF.sub.V] groups from day 28 to 46.

The available published information about the influence of vaccination on piglets' growth performance is varied. According to Oliver-Ferrando et al. [69], the optimal time for PCV2 vaccination is at either 3 or 6 weeks of age. In our study, piglets were vaccinated on day 25 of life. Duivon et al. [70] published that the added PCV2 valence in the vaccination protocol helps counter the negative impact of subclinical PCV2 infection on growth. Jeong et al. [71] indicated that ADG showed improvement in vaccinated compared with non-vaccinated animals. Da Silva et al. [72] compared the ADG between vaccinated and non-vaccinated animals from weaning to finishing for four commercial vaccine products. All products significantly increased ADG values. However, according to Wozniak et al. [73] data from four farms where vaccination was used, the results were similar to those from non-vaccinated farms. The authors suggested revising the vaccination protocol. The above- mentioned findings can be explained by a major PCV2 genotype shift from the predominant PCV2 genotype 2b towards 2d [74], While the commercial vaccines that were first introduced to the US in 2006 have been highly effective in reducing clinical signs and improving production, recent studies have indicated a declining level of PCV2 prevalence and viraemia in the field. Hence, the efficiency of current vaccines against new and emerging strains, as well as new vaccine development, is crucial [75]. Vaccination against PCV2 is an important co-working agent that confers unintended benefits in the protection against the other agents [76]. Notably, the breed information is frequently omitted from experimental publications of vaccine studies, as well as environmental conditions (temperature, stocking density, etc.). These factors are very important for the further standardisation across studies before logical comparisons can be made among studies [77].

While we found differences in the ADG between different groups, the influence of vaccination on different feed groups was the opposite. Specifically, the FCR was lower in the [S.sub.V] compared to the [S.sub.nonV] group. However, the effect was the opposite in the rapeseed meal groups: FCR was lower in the [R.sub.nonV] compared to the [RF.sub.V] group. The lowest FCR (1.38) occurred in the Sy group. Notably, soya-based feed is much more expensive compared with the feed composed of local rapeseed meal. Overall, the data support the use of fermented local feedstock for piglet feeding because it provides similar growth parameters as imported soya.

3.5. Influence of Analysed Factors on Ammonia Emission

Table 6 presents the influence of the analysed factors on ammonia emission. At the end of experiment, the [RF.sub.V] group had the lowest ammonia emission: 58.2, 23.8 and 47.33% lower than the [S.sub.nonV], [S.sub.V], and [RF.sub.nonV] groups, respectively. There was lower ammonia emission in vaccinated groups at the end of the experiment: 45.2% lower in the [S.sub.V] compared to [S.sub.nonV] group and 47.33% lower in the [RF.sub.V] compared to the [RF.sub.nonV] group. ANOVA revealed a significant effect for all the analysed factors and their interaction on ammonia emission. Furthermore, there was a significant, very strong positive correlation between ammonia emission and Y/M count in piglets' faeces at the end of experiment (R = 0.974; p = 0.013).

There has been no information published about the influence of vaccination on ammonia emission; most of the published studies have focussed on dietary aspects. Yi et al. [37] and Lee et al. [78] reported that protected organic acids used for weanling pigs reduce faecal ammonia. Nguyen et al. [79] concluded that diets with probiotics mixture decreased pigs' ammonia emission. According to Wang et al. [51], diets with fermented feed ingredients tended to decrease ammonia emissions, but this effect was not statistically significant. According to Bindas et al. [80], ammonia in the faeces of experimental animals fed with fermented feed was significantly lower compared with the control animals. Reducing ammonia emissions by changing the dietary composition is considered economical and feasible because it can improve nitrogen utilisation and, consequently, reduce ammonia emissions [53]. Lactobacilli-based feed fermentation decreases the emissions of total organic carbon and ammonium [67], Finally, many factors can contribute to ammonia emission on pig farms. Our data indicate that vaccination as a factor should be considered, as well as microbiological parameters of the piglets' faeces. Indeed, we found a very strong correlation between ammonia emission and Y/M count in piglets' faeces.

4. Conclusions

Fermented feed had a positive impact on the amount of Lactobacillus during the post-weaning period of pigs. In addition, vaccination had no negative impact on microbial communities. There was a higher Lactobacillus prevalence in vaccinated compared with non-vaccinated groups, as well as a higher viable LAB count in faeces from both vaccinated groups ([S.sub.V] and [RF.sub.V]) at the end of experiment. There were no significant differences in ADG between piglets' groups. There were differences in FCR: 11.5% lower in the [S.sub.V] compared with the [S.sub.nonV] group, 10.2% lower in the [RF.sub.nonV] compared with the [RF.sub.V] group, and 21.6% lower in the [S.sub.V] compared with the [RF.sub.V] group. There were a significant, very strong positive correlations between FCR and TEC in piglets' faeces (R = 0.919, p = 0.041) and between ammonia emission and Y/M count in piglets' faeces at the end of experiment (R = 0.974, p = 0.013). The lowest ammonia emission was in the [RF.sub.V] group section. Vaccination as a separate factor did not significantly influence piglets' blood parameters. Overall, by changing from an extruded soya to cheaper rapeseed meal and applying the fermentation model with the selected LAB combination, it is possible to feed piglets without any undesirable changes in health and growth performance, as well as in a more sustainable manner. However, to evaluate the influence of vaccination and its interaction with other parameters (feed, piglet age, breed, etc.) on piglets' parameters, additional studies should be performed and methods should be standardised so that the results may be compared.

doi: 10.3390/anil0071201

Supplementary Materials: The following are available online at http://www.mdpi.eom/2076-2615/10/7/1201/sl, Table SI: Species [S.sub.nonV] group before experiment; Table S2: Species [S.sub.V] group before experiment Species Sy group before experiment; Table S3: Species [RF.sub.nonV] group before experiment; Table S4: Species RFV group before experiment; Table S5: Species [S.sub.nonV] group after experiment; Table S6: Species SV group after experiment; Table S7: Species [RF.sub.nonV] group after experiment; Table S8: Species RFV group after experiment; Table S9: Differences between microbiological parameters of the piglets' faeces between all the tested groups; Table S10: Differences between blood parameters of the piglets between all the tested groups.

Author Contributions: Conceptualisation, methodology, E.B., R.G., L.V., S.B. and M.R.; investigation, L.V., 5. B., S.S., A.D., V.S., P.Z., E.Z. and V.L; writing--original draft preparation, L.V., D.K., P.Z., V.S., E.M. and V.L.; writing--review and editing, E.B., V.B. and R.G.; visualisation, P.Z., V.S., V.L., D.K. and E.M.; supervision, E.B. All authors have read and agreed to the published version of the manuscript.

Funding: This research received no external funding.

Acknowledgments: The authors gratefully acknowledge the EUREKA Network Project EI13309 "SUSFEETECE1" (Nr. 01.2.2-MITA-K-702-05-0001) and COST Action CA18101 'SOURDOugh biotechnology network towards novel, healthier and sustainable food and bloproCesseS'.

Conflicts of Interest: The authors declare no conflict of interest.

References

[1.] Tischer, I.; Mields, W.; Wolff, D.; Vagt, M.; Griem, W. Studies on epidemiology and pathogenicity of porcine circovirus. Arch. Virol. 1986, 91, 271-276. [CrossRef]

[2.] Ellis, J.; Hassard, L.; Clark, E.; Harding, J.; Allan, G.; Willson, P; Strokappe, J.; Martin, K.; McNeilly, F.; Meehan, B.; et al. Isolation of circovirus from lesions of pigs with post- weaning multi-systemic wasting syndrome. Can. Vet. J. 1998, 39, 44-51.

[3.] Argiles, J.M.; Busquets, S.; Toledo, M.; Lopez-Soriano, F.J. The role of cytokines in cancer cachexia. Curr. Opin. Support Palliat. Care 2009, 3, 263-268. [CrossRef] [PubMed]

[4.] Ottenhoff, T.H.M. The knowns and unknowns of the immunopathogenesis of tuberculosis, bit. J. Tuberc. Lung Dis. 2012,16,1424--1432. [CrossRef] [PubMed]

[5.] Szabo, G.; Csak, T. Inflammasomes in liver diseases. J. Hepatol. 2012, 57, 642-654. [CrossRef]

[6.] Ramamoorthy, S.; Meng, X.-J. Porcine circoviruses: A minuscule yet mammoth paradox. Anim. Health Res. Rev. 2009,10,1-20. [CrossRef]

[7.] Gillespie, J.; Opriessnig, T.; Meng, X.J.; Pelzer, K.; Buechner-Maxwell, V. Porcine circovirus type 2 and porcine circovirus-associated disease. J. Vet. Intern. Med. 2009,23,1151-1163. [CrossRef]

[8.] Csagola, A.; Zadori, Z.; Meszaros, I.; Tuboly, T. Detection of porcine parvovirus 2 (Ungulate Tetraparvovirus 3) Specific antibodies and examination of the serological profile of an infected swine herd. PLoS ONE 2016, 11, e0151036. [CrossRef]

[9.] Novosel, D.; Cadar, D.; Tuboly, T.; Jungic, A.; Stadejek, T.; Ait-Ali, T.; Csagola, A. Investigating porcine parvoviruses genogroup 2 infection using in situ polymerase chain reaction. BMC Vet. Res. 2018,14,163. [CrossRef] [PubMed]

[10.] Thomson, J.; Smith, B.; Alan, G.; McNeilly, F.; McVicar, C. PDNS, PMWS and porcine circovirus type 2 in Scotland. Vet. Rec. 2000,146, 651-652.

[11.] Dan, A.; Molnar, T.; Biksi, I.; Glavits, R.; Shaheim, M.; Harrach, B. Characterisation of Hungarian porcine circovirus 2 genomes associated with PMWS and PDNS cases. Acta Vet. Hung. 2003,51, 551-562. [CrossRef]

[12.] An, D.; Roh, I.; Song, D.; Park, C.; Park, B. Phylogenetic characterization of porcine circovirus type 2 in PMWS and PDNS Korean pigs between 1999 and 2006. Virus Res. 2007,129,115-122. [CrossRef] [PubMed]

[13.] Zheng, G.; Lu, Q.; Wang, F.; Xing, G.; Feng, H.; Jin, Q.; Guo, Z.; Teng, M.; Hao, H.; Li, D.; et al. Phylogenetic analysis of porcine circovirus type 2 (PCV2) between 2015 and 2018 in Henan Province, China. BMC Vet. Res. 2020,16, 6. [CrossRef] [PubMed]

[14.] Xiao, C.-T.; Halbur, P.G.; Opriessnig, T. Global molecular genetic analysis of porcine circovirus type 2 (PCV2) sequences confirms the presence of four main PCV2 genotypes and reveals a rapid increase of PCV2d. J. Gen. Virol. 2015, 96,1830-1841. [CrossRef]

[15.] Liu, J.; Wei, C.; Dai, A.; Lin, Z.; Fan, K.; Fan, J.; Liu, J.; Luo, M.; Yang, X. Detection of PCV2e strains in Southeast China. Peer] 2018, 6, e4476. [CrossRef]

[16.] Opriessnig, T.; Xiao, C.-T.; Gerber, P.F.; Halbur, P.G. Identification of recently described porcine parvoviruses in archived North American samples from 1996 and association with porcine circovirus associated disease. Vet. Microbiol. 2014,173, 9-16. [CrossRef]

[17.] Chen, N.; Huang, Y.; Ye, M.; Li, S.; Xiao, Y.; Cui, B.; Zhu, J. Co- infection status of classical swine fever virus (CSFV), porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circoviruses (PCV2 and PCV3) in eight regions of China from 2016 to 2018. Infect. Genet. Evol. 2019, 68,127-135. [CrossRef] [PubMed]

[18.] Bartkiene, E.; Bartkevics, V.; Krungleviciute, V.; Pugajeva, I.; Zadeike, D.; Juodeikiene, G. Lactic acid bacteria combinations for wheat sourdough preparation and their influence on wheat bread quality and acrylamide formation. J. Food Sci. 2017, 82, 2371-2378. [CrossRef]

[19.] Bartkiene, E.; Bartkevics, V.; Lele, V.; Pugajeva, I.; Zavistanaviciute, R; Mickiene, R.; Zadeike, D.; Juodeikiene, G. A concept of mould spoilage prevention and acrylamide reduction in wheatbread: Application of lactobacilli in combination with a cranberry coating. Food Control 2018, 91, 284-293. [CrossRef]

[20.] Bartkiene, E.; Sakiene, V.; Bartkevics, V.; Juodeikiene, G.; Lele, V.; Wiacek, C.; Braun, P.G. Modulation of the nutritional value of lupine wholemeal and protein isolates using submerged and solid-state fermentation with Pediococcus pentosaceus strains. Int. J. Food Sci. Technol. 2018, 53,1896- 1905. [CrossRef]

[21.] Bartkiene, E.; Sakiene, V.; Lele, V.; Bartkevics, V.; Rusko, J.; Wiacek, C.; Ruzauskas, M.; Braun, P.G.; Matusevicius, P.; Zdunczyk, Z.; et al. Perspectives of lupine wholemeal protein and protein isolates biodegradation. Int. J. Food Sci. Technol. 2019, 54,1989-2001. [CrossRef]

[22.] Bartkiene, E.; Mozuriene, E.; Lele, V.; Zokaityte, E.; Gruzauskas, R.; Jakobsone, I.; Juodeikiene, G.; Ruibys, R.; Bartkevics, V. Changes of bioactive compounds in barley industry by-products during submerged and solid state fermentation with antimicrobial Pediococcus acidiladici strain LUHS29. Food Sci. Nutr. 2020, 8, 340-350. [CrossRef] [PubMed]

[23.] Vadopalas, L.; Ruzauskas, M.; Lele, V.; Starkute, V.; Zavistanaviciute, P; Zokaityte, E.; Bartkevics, V.; Badaras, S.; Klupsaite, D.; Mozuriene, E.; et al. Pigs' feed fermentation model with antimicrobial lactic acid bacteria strains combination by changing extruded soya to biomodified local feed stock. Animals 2020, 10, 783. [CrossRef] [PubMed]

[24.] European Union Law. European Parliament Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes Text with EEA Relevance. Available online: https://eur-lex.europa.eu/legal- content/EN/TXT/?uri=celex%3A32010L0063 (accessed on 13 July 2020).

[25.] Hthuanian Director of the State Food and Veterinary Service. Bl-866 Del Mokslo ir mokymo tikslais naudojamu gyvunu laikymo, prieziuros ir naudojimo reikalavimu patvirtinimo. Available online: https://e- seimas.lrs.lt/portal/legalAcf/lVT AD/TAB.437081?position]nSearchResults=0&searchModelUU]D=64alf51f-6356-4b60-a21e- 3a67ac3bll07 (accessed on 10 March 2020).

[26.] National Research Council. Nutrient Requirements of Swine: Eleventh Revised Edition; The National Academies Press: Washington, DC, USA, 2012.

[27.] AOAC. Official Methods of Analysis, 21st ed.; AOAC International: Rockland, MD, USA, 2019.

[28.] Merkeviciene, L.; Ruzauskaite, N.; Klimiene, I.; Siugzdiniene, R.; Dailidaviciene, J.; Virgailis, M.; Mockeliunas, R.; Ruzauskas, M. Microbiome and antimicrobial resistance genes in microbiota of cloacal samples from European herring gulls (Lams Argentatus). J. Vet. Res. 2017, 4, 27- 35. [CrossRef]

[29.] Zavistanaviciute, P.; Poskiene, I.; Lele, V.; Antanaitis, R.; Kantautaite, J.; Bartkiene, E. The influence of the newly isolated Lactobacillus plantarum LUHS135 and Lactobacillus paracasei LUHS244 strains on blood and faeces parameters in endurance horses. Pol. J. Vet. Sci. 2019, 22, 513-521. [CrossRef]

[30.] The Lithuanian Minister of Environment. Dl-862. Del Lietuvos Respublikos Aplinkos Apsaugos Normatyvinio Dokumento LAND 88-2009 "Amoniako Koncentracijos Nustatymas Aplinkos Ore Spektrometriniu Metodu" Patvirtinimo. Available online: https://e- seimas.lrs.lt/portal/legalAct/lt/TAD /TAIS.363222 (accessed on 13 July 2020).

[31.] Pajarillo, E.A.B.; Chae, J.P.; Kim, H.B.; Kim, I.H.; Kang, D.-K. Barcoded pyrosequencing-based metagenomic analysis of the faecal microbiome of three purebred pig lines after cohabitation. Appl. Microbiol. Biotechnol. 2015, 99, 5647-5656. [CrossRef]

[32.] Round, J.L.; Mazmanian, S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009, 9, 313-323. [CrossRef]

[33.] Benson, A.K.; Kelly, S.A.; Legge, R.; Ma, F.; Low, S.J.; Kim, J.; Zhang, M.; Oh, P.L.; Nehrenberg, D.; Hua, K.; et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc. Natl. Acad. Sci. USA 2010,107,18933-18938. [CrossRef]

[34.] Leamy, L.J.; Kelly, S.A.; Nietfeldt, J.; Legge, R.M.; Ma, F.; Hua, K.; Sinha, R.; Peterson, D.A.; Walter, J.; Benson, A.K.; et al. Host genetics and diet, but not immunoglobulin A expression, converge to shape compositional features of the gut microbiome in an advanced intercross population of mice. Genome Biol. 2014,15, 552. [CrossRef]

[35.] Frese, S.A.; Parker, K.; Calvert, C.C.; Mills, D.A. Diet shapes the gut microbiome of pigs during nursing and weaning. Microbiome 2015, 3, 28. [CrossRef] [PubMed]

[36.] Le Floc'h, N.; Knudsen, C.; Gidenne, T.; Montagne, L.; Merlot, E. Impact of feed restriction on health, digestion and faecal microbiota of growing pigs housed in good or poor hygiene conditions. Animal 2014, 8, 1632-1642. [CrossRef] [PubMed]

[37.] Yang, Q.; Huang, X.; Wang, R; Yan, Z.; Sun, W.; Zhao, S. Longitudinal development of the gut microbiota in healthy and diarrheic piglets induced by age-related dietary changes. Microbiology open 2019, 8, e923. [CrossRef] [PubMed]

[38.] Lamendella, R.; Domingo, J.W.; Ghosh, S.; Martinson, J.; Oerther, D.B. Comparative fecal metagenomics unveils unique functional capacity of the swine gut. BMC Microbiol. 2011,15,103. [CrossRef] [PubMed]

[39.] Pajarillo, E.A.B.; Chae, J.-P.; Balolong, M.P.; Kim, H.B.; Kang, D.-K. Assessment of fecal bacterial diversity among healthy piglets during the weaning transition. J. Gen. Appl. Microbiol. 2014, 60,140-146. [CrossRef]

[40.] Ivarsson, E.; Roos, S.; Liu, H.Y.; Lindberg, J.E. Fermentable non-starch polysaccharides increase the abundance of Bacteroides-Prevotella-Porphyromonas in ileal microbial community of growing pigs. Animal 2014, 8, 1777-1787. [CrossRef] [PubMed]

[41.] Rho, J.; Wright, D.P.; Christie, D.L.; Clinch, K.; Furneaux, R.H.; Roberton, A.M. A novel mechanism for desulfation of mucin: Identification and cloning of a mucin-desulfating glycosidase (sulfoglycosidase) from Prevotella strain RS2. J. Bacteriol. 2005,187,1543-1551. [CrossRef] [PubMed]

[42.] Delia, E.; Tafaj, M.; Manner, K. Efficiency of Probiotics in Farm Animals. Available online: https://www.inte chopen.com/books/probiotic-in-animals/efficiency-of-probiotics-in-farm-animals (accessed on 17 May 2020).

[43.] Valeriano, V.D.V.; Balolong, M.P.; Kang, D.-K. Probiotic roles of Lactobacillus sp. in swine: Insights from gut microbiota. J. Appl. Microbiol. 2017,122, 554--567. [CrossRef]

[44.] Ganzle, M.G.; Follador, R. Metabolism of oligosaccharides and starch in lactobacilli: A review. Front. Microbiol. 2012, 3,340. [CrossRef]

[45.] Konstantinov, S.R.; Awati, A.A.; Williams, B.A.; Miller, B.G.; Jones, P.; Stokes, C.R.; Akkermans, A.D.L.; Smidt, H.; de Vos, W.M. Post-natal development of the porcine microbiota composition and activities. Environ. Microbiol. 2006,8,1191-1199. [CrossRef]

[46.] Dou, S.; Gadonna-Widehem, P.; Rome, V.; Hamoudi, D.; Rhazi, L.; Lakhal, L.; Larcher, T.; Bahi-Jaber, N.; Pinon-Quintana, A.; Guyonvarch, A.; et al. Characterisation of early-life fecal microbiota in susceptible and healthy pigs to post-weaning diarrhoea. PLoS ONE 2017,12, e0169851. [CrossRef]

[47.] Canibe, N.; Jensen, B.B. Fermented liquid feed--Microbial and nutritional aspects and impact on enteric diseases in pigs. Anim. Feed Sci. Technol. 2012,173,17-40. [CrossRef]

[48.] Grela, E.R.; Czech, A.; Kiesz, M.; Wlazlo, L.; Nowakowicz-Dgbek, B. A fermented rapeseed meal additive: Effects on production performance, nutrient digestibility, colostrum immunoglobulin content and microbial flora in sows. Anim. Nutr. 2019, 5, 373-379. [CrossRef] [PubMed]

[49.] Mach, N.; Berri, M.; Estelle, J.; Levenez, F.; Lemonnier, G.; Denis, C.; Leplat, J.-J.; Chevaleyre, C.; Billon, Y.; Dore, J.; et al. Early-life establishment of the swine gut microbiome and impact on host phenotypes. Environ. Microbiol. Rep. 2015, 7, 554--569. [CrossRef]

[50.] Shin, D.; Chang, S.Y.; Bogere, R; Won, K.; Choi, J.-Y.; Choi, Y.-J.; Lee, H.K.; Hur, J.; Park, B.-Y.; Kim, Y.; et al. Beneficial roles of probiotics on the modulation of gut microbiota and immune response in pigs. PLoS ONE 2019,14, e0220843. [CrossRef]

[51.] Wang, L.; Zhu, L.; Qin, S. Gut microbiota modulation on intestinal mucosal adaptive immunity. J. Immunol. Res. 2019, 2019, 4735040. [CrossRef] [PubMed]

[52.] Slifierz, M.J.; Friendship, R.; Weese, J.S. Zinc oxide therapy increases prevalence and persistence of methicillin-resistant Staphylococcus aureus in pigs: A randomized controlled trial. Zoonoses Public Health 2015, 62, 301-308. [CrossRef]

[53.] Chen, L.; Xu, Y.; Chen, X.; Fang, C.; Zhao, L.; Chen, F. The maturing development of gut microbiota in commercial piglets during the weaning transition. Front. Microbiol. 2017, 8,1688. [CrossRef]

[54.] Bian, G.; Ma, S.; Zhu, Z.; Su, Y.; Zoetendal, E.G.; Mackie, R.; Liu, J.; Mu, C.; Huang, R.; Smidt, H.; et al. Age, introduction of solid feed and weaning are more important determinants of gut bacterial succession in piglets than breed and nursing mother as revealed by a reciprocal cross- fostering model. Environ. Microbiol. 2016,18,1566-1577. [CrossRef]

[55.] Levesque, C.L.; Hooda, S.; Swanson, K.S.; de Lange, K. Alterations in ileal mucosa bacteria related to diet complexity and growth performance in young pigs. PLoS ONE 2014, 9, el08472. [CrossRef]

[56.] Zhu, L.; Liao, R.; Tu, W.; Lu, Y.; Cai, X. Pyrodextrin enhances intestinal function through changing the intestinal microbiota composition and metabolism in early weaned piglets. Appl. Microbiol. Biotechnol. 2020, 104, 4141-4154. [CrossRef]

[57.] Zimmermann, P.; Curtis, N. The influence of probiotics on vaccine responses--A systematic review. Vaccine 2018, 36, 207-213. [CrossRef] [PubMed]

[58.] Dowarah, R.; Verma, A.K.; Agarwal, N.; Singh, P; Singh, B.R. Selection and characterization of probiotic lactic acid bacteria and its impact on growth, nutrient digestibility, health and antioxidant status in weaned piglets. PLoS ONE 2018,13, e0192978. [CrossRef] [PubMed]

[59.] Arfken, A.M.; Frey, J.F.; Ramsay, T.G.; Summers, K.L. Yeasts of burden: Exploring the mycobiome-bacteriome of the piglet GI tract. Front. Microbiol. 2019,10, 2286. [CrossRef] [PubMed]

[60.] Xu, X.; Li, L.-M.; Li, B.; Guo, W.-J.; Ding, X.-L.; Xu, F.-Z. Effect of fermented biogas residue on growth performance, serum biochemical parameters, and meat quality in pigs. Asian Austral. J. Anim. Sci. 2017, 30, 1464--1470. [CrossRef]

[61.] Czech, A.; Grela, E.; Kiesz, M.; Klys, S. Biochemical and haematological blood parameters of sows and piglets fed a diet with a dried fermented rapeseed meal. Ann. Anim. Sci. 2020, 20, 535- 550. [CrossRef]

[62.] Shi, C.; He, J.; Wang, J.; Yu, J.; Yu, B.; Mao, X.; Zheng, P; Huang, Z.; Chen, D. Effects of Aspergillus niger fermented rapeseed meal on nutrient digestibility, growth performance and serum parameters in growing pigs. Anim. Sci. J. 2016, 87, 557-563. [CrossRef]

[63.] Cho, J.; Min, B.; Chen, Y.; Yoo, J.S.; Wang, Q. Evaluation of FSP (fermented soy protein) to replace soybean meal in weaned pigs: Growth performance, blood urea nitrogen and total protein concentrations in serum and nutrient digestibility. Asian Austral. J. Anim. Sci. 2007,20,1874-1879. [CrossRef]

[64.] Min, B. Effects of diet complexity and fermented soy protein on growth performance and apparent ileal amino acid digestibility in weanling pigs. Asian Austral. J. Anim. Sci. 2010,23,1496-1502. [CrossRef]

[65.] Zhu, J.; Gao, M.; Zhang, R.; Sun, Z.; Wang, C.; Yang, F.; Huang, T.; Qu, S.; Zhao, L.; Li, Y.; et al. Effects of soybean meal fermented by L. plantarum, B. subtilis and S. cerevisieae on growth, immune function and intestinal morphology in weaned piglets. Microb. Cell Fact. 2017,16,191. [CrossRef]

[66.] Liu, X.; Feng, J.; Xu, Z. The effects of fermented soybean meal on growth performance and immune characteristics in weaned piglets. Turk. J. Vet. Anim. Sci. 2007, 31, 341-345.

[67.] Jeong, Y.D.; Ko, H.S.; Hosseindoust, A.; Choi, Y.H.; Chae, B.J.; Yu, D.J.; Cho, E.S.; Cho, K.H.; Shim, S.M.; Ra, C.S.; et al. Lactobacillus-based fermentation product and lactose level in the feed for weanling pigs: Effects on intestinal morphology, microbiota, gas emission, and targeted intestinal coliforms. Livest. Sci. 2019,227, 90-96. [CrossRef]

[68.] Satessa, G.D.; Tamez-Hidalgo, P.; Hui, Y.; Cieplak, T.; Krych, L.; Kjaerulff, S.; Brunsgaard, G.; Nielsen, D.S.; Nielsen, M.O. Impact of dietary supplementation of lactic acid bacteria fermented rapeseed with or without macroalgae on performance and health of piglets following omission of medicinal zinc from weaner diets. Animals 2020,10,137. [CrossRef] [PubMed]

[69.] Oliver-Ferrando, S.; Segales, J.; Lopez-Soria, S.; Callen, A.; Merdy, O.; Joisel, F.; Sibila, M. Evaluation of natural porcine circovirus type 2 (PCV2) subclinical infection and seroconversion dynamics in piglets vaccinated at different ages. Vet. Res. 2016, 47,121. [CrossRef]

[70.] Duivon, D.; Correge, I.; Hemonic, A.; Rigaut, M.; Roudaut, D.; Jolie, R. Field evaluation of piglet vaccination with a Mycoplasma hyopneumoniae bacterin as compared to a ready-to-use product including porcine circovirus 2 and M. hyopneumoniae in a conventional French farrow-to-finish farm. Pore. Health Manag. 2018,4,4. [CrossRef] [PubMed]

[71.] Jeong, J.; Park, C.; Choi, K.; Chae, C. Comparison of three commercial one-dose porcine circovirus type 2 (PCV2) vaccines in a herd with concurrent circulation of PCV2b and mutant PCV2b. Vet. Microbiol. 2015,177, 43-52. [CrossRef] [PubMed]

[72.] da Silva, N.; Carriquiry, A.; O'Neill, K.; Opriessnig, T.; O'Connor, A.M. Mixed treatment comparison meta-analysis of porcine circovirus type 2 (PCV2) vaccines used in piglets. Prev. Vet. Med. 2014,117,413-424. [CrossRef]

[73.] Wozniak, A.; Milek, D.; Matyba, P.; Stadejek, T. Real-time PCR detection patterns of porcine circovirus type 2 (PCV2) in Polish farms with different statuses of vaccination against PCV2. Viruses 2019,11,1135. [CrossRef]

[74.] Opriessnig, T.; Xiao, C.-T.; Halbur, P.G.; Gerber, P.F.; Matzinger, S.R.; Meng, X.-J. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naive pigs under experimental conditions. Vaccine 2017, 35, 248- 254. [CrossRef]

[75.] Afghah, Z.; Webb, B.; Meng, X.-J.; Ramamoorthy, S. Ten years of PCV2 vaccines and vaccination: Is eradication a possibility? Vet. Microbiol. 2017, 206, 21-28. [CrossRef]

[76.] Chae, C. Porcine respiratory disease complex: Interaction of vaccination and porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae. Vet. J. 2016, 212,1-6. [CrossRef]

[77.] Patterson, R.; Nevel, A.; Diaz, A.V.; Martineau, H.M.; Demmers, T.; Browne, C.; Mavrommatis, B.; Werling, D. Exposure to environmental stressors result in increased viral load and further reduction of production parameters in pigs experimentally infected with PCV2b. Vet. Microbiol. 2015, 177, 261-269. [CrossRef] [PubMed]

[78.] Lee, D.J.; Yang, Y.; Jung, H.I.; Nguyen, D.H.; Kim, I.H. Effect of a protected blend of organic acids and medium-chain fatty acids on growth performance, nutrient digestibility, blood profiles, meat quality, faecal microflora, and faecal gas emission in finishing pigs. Can. J. Anim. Sci. 2019, 99,448-455.

[79.] Nguyen, D.H.; Nyachoti, C.; Kim, I.H. Evaluation of effect of probiotics mixture supplementation on growth performance, nutrient digestibility, faecal bacterial enumeration, and noxious gas emission in weaning pigs. Ital. J. Anim. Sci. 2019,18,466-473. [CrossRef]

[80.] Bindas, L.; Bujnak, L.; Maskal'ova, I.; Mihok, T.; Lackova, P.; Nad, P. Effects of feeding low protein diets on serum and faeces parameters in weaned piglets. Folia Vet. 2019, 63, 37-44. [CrossRef]

Laurynas Vadopalas (1), Sarunas Badaras (1), Modestas Ruzauskas (2,3)[ID], Vita Lele (1,4), Vytaute Starkute (1,4), Paulina Zavistanaviciute (1,4), Egle Zokaityte (1,4), Vadims Bartkevics (5,6), Dovile Klupsaite (1), Erika Mozuriene (1,4), Agila Dauksiene (1,2), Sonata Sidlauskiene (4), Romas Gruzauskas (7), Elena Bartkiene (1,4),*[ID]

(1) Institute of Animal Rearing Technologies, Lithuanian University of Health Sciences, Tilzes g. 18, LT-47181 Kaunas, Lithuania; laurynas.vadopalas@lsmuni.lt (L.V.); sarunas.badaras@gmail.com (S.B.); vita.lele@lsmuni.lt (V.L.); vytaute.starkute@lsmuni.lt (V.S.); paulina.zavistanaviciute@lsmuni.lt (P.Z.); egle.zokaityte@lsmuni.lt (E.Z.); dovile.klupsaite@lsmuni.lt (D.K.); erika.mozuriene@lsmuni.lt (E.M.); agila.dauksiene@lsmuni.lt (A.D.); sonata.sidlauskiene@lsmuni.lt (S.S.)

(2) Department of Physiology and Anatomy, Lithuanian University of Health Sciences, Tilzes g. 18, LT-47181 Kaunas, Lithuania; modestas.ruzauskas@lsmuni.lt

(3) Microbiology and Virology Institute, Lithuanian University of Health Sciences, Tilzes g. 18, LT-47181 Kaunas, Lithuania

(4) Department of Food Safety and Quality, Lithuanian University of Health Sciences, Tilzes g. 18, LT-47181 Kaunas, Lithuania

(5) University of Latvia Faculty of Chemistry, Jelgavas iela 1, LV-1004 Riga, Latvia; vadims.bartkevics@bior.gov.lv

(6) Institute of Food Safety, Animal Health and Environment BIOR, Lejupesiela 3, LV-1076 Riga, Latvia

(7) Department of Food Science and Technology, Kaunas University of Technology, Radvilenu str. 19, LT-50254 Kaunas, Lithuania; romas.gruzauskas@ktu.lt

* Correspondence: elena.bartkiene@lsmuni.lt; Tel: +370-601-35837

Received: 2 June 2020; Accepted: 13 July 2020; Published: 15 July 2020

Caption: Figure 1. Scheme of fermented feed preparation. The technological lactic acid bacteria (LAB) biomass consisted of Lactobacillus plantation LUHS122, Lactobacillus casei LUHS210, Lactobacillus farraginis LUHS206, Pediococcus acidilactici LUHS29, Lactobacillus plantation LUHS135 and Lactobacillus uvarum LUHS245.

Caption: Figure 2. Microbial profiles (prevalence, %) at the genus level in pig faeces before the experiment.
Table 1. Diet composition (dry matter 87 %).

Ingredients (%)                         Control   Treated
                                        Group     Group

Barley                                  38.45     33.25
Rapeseed meal                           --        25.00
Wheat                                   32.12     25.00
Soya beans (extruded)                   9.30      --
Potato protein                          5.00      2.00
Soybean protein concentrate             2.00      --
Whey powder                             5.80      5.80
Sunflower oil                           2.72      4.51
Limestone                               1.48      1.1
NaCl                                    0.38      0.35
Monocalcium phosphate                   0.33      0.41
L-Lysine sulphate                       0.87      1.1
DL-Methionine                           0.25      0.16
Acidal NC (formic and acetic acids)     0.30      0.30
1 Vitamins and trace elements (premix)  1.00      1.00

Nutritional value

ME swine (MJ/kg)                        13.86     13.95
Crude protein (%)                       19.00     19.00
Crude fat (%)                           6.51      6.51
Crude fibre (%)                         3.15      5.14
Lysine (%)                              1.45      1.45
Methionine (%)                          0.55      0.55
Threonine (%)                           0.93      0.94
Tryptophan (%)                          0.26      0.25
Methionine + Cystine (%)                0.87      0.88
Ca (%)                                  0.90      0.90
Total P (%)                             0.59      0.62
Available P (%)                         0.37      0.38
Na (%)                                  0.20      0.21

ME-metabolisable energy. (1) Composition of premix per 1 kg of feed:
Vitamin A-18,180 IU; vitamin D3-2040 IU; vitamin E-161 mg [kg.sup.-1];
vitamin K3--5.03 mg; thiamine--3.64 mg; riboflavin--9.16 mg; choline
chloride--404 mg; pyridoxine--4.60 mg; vitamin B12--0.05 mg;
niacin--41 mg; pantothenic acid-22.85 mg; folic acid--1.85 mg;
biotin--0.21 mg; Fe--152 mg; Cu--100 mg; Zn--91 mg; Mn-80 mg; I--0.81
mg; Co--0.53 mg; Se--0.30 mg.

Table 2. Microbiological parameters in faeces from 25- and 61-day-old
piglets.

Microbiological   Day
Parameters                   SnonV
(logio CFU/g)

LAB               Baseline   7.78 [+ or -] 0.03 (A;a)
                  61         6.22 [+ or -] 0.04 (B;a)
TVC               Baseline   7.08 [+ or -] 0.02 (A;a)
                  61         6.41 [+ or -] 0.04 (B;a)
TEC               Baseline   7.22 [+ or -] 0.06 (A;a)
                  61         6.36 [+ or -] 0.02 (Bb)
Y/M               Baseline   6.73 [+ or -] 0.04 (A;a)
                  61         6.36 + 0.08 (Bb)

Tests of between-subject effects: influence of the analysed factors
and their interactions on microbiological parameters in piglets'
faeces Dependent VariableTreatment DFermented Feed

Significance of the differences between groups (p)

LAB               0.0001     0.0001
TBC               0.0001     0.0001
TVC               0.0001     0.0001
Y/M               0.0001     0.0001

Microbiological   Treatments
Parameters        [S.sub.V]                  [RF.sub.nonV]
(logio CFU/g)

LAB               8.22 [+ or -] 0.04 (Ab)    8.33 [+ or -] 0.05 (A;a)
                  8.47 [+ or -] 0.02 (Bb)    5.17 [+ or -] 0.06 (B;a)
TVC               8.25 [+ or -] 0.05 (Ab)    8.38 [+ or -] 0.07 (Ab)
                  8.24 [+ or -] 0.03 (Ab)    6.40 [+ or -] 0.03. (B;a)
TEC               7.79 [+ or -] 0.06 (Ab)    7.40 [+ or -] 0.08 (A;a)
                  6.18 [+ or -] 0.05 (B;a)   6.87 [+ or -]0.07 (B;a)
Y/M               7.71 [+ or -] 0.08 (Ab)    6.21 [+ or -] 0.04 (A;a)
                  4.31 + 0.06 (B;a)          5.72[+ or -] 0.05 (B;a)

Tests of between-subject effects: influence of the analysed factors
and their interactions on microbiological parameters in piglets'
faeces
Dependent VariableVaccination                Treatment Duration
                                             x Fermented Feed

Significance of the differences between groups (p)

LAB               0.0001                     0.0001
TBC               0.0001                     0.0001
TVC               0.001                      0.0001
Y/M               0.0001                     0.0001

Microbiological
Parameters        RFV
(logio CFU/g)

LAB               8.35 [+ or -] 0.06 (A;a)
                  6.24 [+ or -] 0.07 (B;b)
TVC               7.68 [+ or -] 0.07 (A;a)
                  7.42 [+ or -] 0.08 (Bb)
TEC               7.58 [+ or -] 0.04 (Ab)
                  7.12 [+ or -] 0.03 (Bb)
Y/M               6.63 [+ or -] 0.04 (Ab)
                  6.26[+ or -] 0.04 (Bb)


Tests of between-subject effects: influence of the analysed factors
and their interactions on microbiological parameters in piglets'
faeces
Dependent Variable-Treatment Duration         Fermented Feed
                  x Vaccination              x Vaccination

Significance of the differences between groups (p)

LAB               0.0001                     0.0001
TBC               0.0001                     0.246
TVC               0.021                      0.0001
Y/M               0.0001                     0.0001

Microbiological
Parameters
(logio CFU/g)

LAB
TVC
TEC
Y/M

Tests of between-subject effects: influence of the analysed factors
and their interactions on microbiological parameters in piglets'
faeces
Dependent Variable-Treatment Duration
                  x Fermented Feed
                  x Vaccination
Significance of the differences between groups (p)

LAB               0.0001
TBC               0.0001
TVC               0.0001
Y/M               0.0001

[S.sup.nonV]--non-vacdnated piglets fed with control group compound
feed; [S.sub.v]--vaccinated piglets fed with control group compound
feed; [RF.sub.nonV]-non-vacdnated piglets fed with fermented compound
feed; [RF.sub.v]--vaccinated piglets fed with fermented compound feed.
CFU-colony forming units; LAB--lactic acid bacteria; TVC--total viable
bacteria count; TEC--total enterobacteria count; Y/M--yeast/mould
count. Measurements were made at baseline--day 25, before the start
of the feeding experiment-and on day 61, the end of the experiment.
(A,B) Different uppercase letters indicate significant treatment
duration-related differences (p [less than or equal to] 0.05). (a,b)
Different lowercase letters indicate differences among treatments,
comparing [S.sub.nonV] and [S.sub.V]; [RF.sub.nonV] and [RF.sub.V]
(p [less than or equal to] 0.05). Data are presented as mean values
[+ or -] standard error (n = 10 per group).

Table 3. Piglets' blood parameters.

Blood Parameters             Day                       Treatments
                                        [S.sub.nonV]   [S.sub.V]

Aspartate aminotransferase   Baseline   29.4 (A;a)     42.67 (A;a)
  (AST), U/L                 61         34.0 (B;a)     41.0. (A;a)
Alanine aminotransferase     Baseline   48.4 (A;a)     43.67 (A;a)
  (ALT), U/L                 61         76.2. (B;a)    69.6 (B;a)
Cholesterol (Chol),          Baseline   1.64 (A;a)     1.64 (A;a)
  mmol/L                     61         2.06. (B;a)    2.26. (B;a)
High-density lipoprotein     Baseline   0.714 (A;a)    0.744 (A;b)
  cholesterol
(HDL-C), mmol/L              61         0.840 (B;a)    0.944 (B;a)
Low-density lipoprotein      Baseline   0.758 (A;a)    0.726 (A;a)
  cholesterol
(LDL-C), mmol/L              61         0.980 (B;a)    1.102 (B;a)
Triglycerides (TG), mmol/L   Baseline   0.360 (A;a)    0.372 (A;a)
                             61         0.466 (B;a)    0.466 (A;a)
Total protein (TP), g/L      Baseline   46.2 (A;a)     44.9 (A;a)
                             61         51.8 (B;a)     56.3 (B;a)
Albumin (ALB), g/L           Baseline   30.0 (A;a)     29.0 (A;a)
                             61         35.8 (A;a)     37.4 (B;a)
Immunoglobulin IgG, g/L      Baseline   2.65 (A;a)     2.85 (A;a)
                             61         3.74 (B;a)     3.44 (A;a)
Triiodothyronine (T3),       Baseline   1.21 (A;a)     1.14 (A;b)
  nmol/L                     61         2.14 (B;a)     2.02 (B;a)
Thyroxine (T4), p d/L        Baseline   4.50 (A;a)     4.82 (A;a)
                             61         4.84 (A;a)     3.84 (A;b)
Glucose (GLU), nmol/L        Baseline   5.84 (A;a)     6.10 (A;a)
                             61         5.74 (A;a)     6.22 (A;b)
Phosphorus (IP), mmol/L      Baseline   2.94 (A;a)     2.87 (A;a)
                             61         3.50 (B;a)     3.39 (A;b)
Magnesium (Mg), mmol/L       Baseline   1.02 (A;a)     0.928 (A;b)
                             61         1.07 (A;a)     0.936 (A;b)
Potassium (K)                Baseline   4.96 (A;a)     5.66 (A;b)
                             61         5.81 (B;a)     5.34 (B;a)
Sodium (Na)                  Baseline   143.4 (A;a)    141.0 (A;a)
                             61         147.2 (A;a)    147.2 (B;a)
Iron (Fe), pmol/L            Baseline   23.6 (A;a)     23.8 (A;a)
                             61         28.1 (A;a)     26.9 (B;a)
Calcium (Ca), nmol/L         Baseline   2.60 (A;a)     2.57 (A;a)
                             61         2.87 (A;a)     2.78 (B;a)
Vitamin B12, pmol/L          Baseline   142.2 (A;a)    93.8 (A;b0
                             61         214.6 (A;a)    122.2 (B;a)
Creatinine (CREA), pmol/L    Baseline   64.2 (A;a)     57.4 (A;a)
                             61         57.4 (A;a)     54.8 (A;a)
Alkaline phosphatase (AP),   Baseline   336.2 (A;a)    285.0 (A;a)
  U/L                        61         263.6 (A;a)    220.4 (A;a)
Urea, mmol/L                 Baseline   2.36 (A;a)     3.26 (A;a)
                             61         2.02 (A;a)     2.38 (A;a)
Thyroid-stimulating          Baseline   0.0200 (A;a)   0.0190 (A;a)
  hormone (TSH)              61         0.0208 (A;a)   0.0228 (A;a)
Total bilirubin (pmol/L)     Baseline   1.88 (A;a)     1.99 (A;a)
                             61         1.98 (A;a)     1.99 (A;a)

Blood Parameters
                             [RF.sub.nonV]   [RF.sub.V]

Aspartate aminotransferase   51.4 (A;a)      61.8 (A;a)
  (AST), U/L                 44.0. (A;a)     42.4. (A;a)
Alanine aminotransferase     53.2 (A;b)      60.8 (A;a)
  (ALT), U/L                 87.0 (B;a)      80.8 (A;b)
Cholesterol (Chol),          1.88 (A;a)      2.04 (A;a)
  mmol/L                     2.34. (A;a)     2.25. (B;a)
High-density lipoprotein     0.898 (A;a)     0.846 (A;a)
  cholesterol
(HDL-C), mmol/L              1.028 (B;a)     0.872 (A;b)
Low-density lipoprotein      0.814 (A;a)     0.976 (A;a)
  cholesterol
(LDL-C), mmol/L              1.032 (A;a)     0.860 (A;b)
Triglycerides (TG), mmol/L   0.366 (A;a)     0.478 (A;a)
                             0.620 (B;a)     0.650 B;b
Total protein (TP), g/L      44.2 (A;a)      45.6 (A;a)
                             52.8 (B;a)      49.5 (B;b)
Albumin (ALB), g/L           32.6 (A;a)      32.8 (A;a)
                             36.2 (A;a)      33.4 (B;b)
Immunoglobulin IgG, g/L      2.35 (A;a)      2.96 (A;a)
                             3.05 (B;a)      5.45 (A;b)
Triiodothyronine (T3),       1.29 (A;a)      1.22 (A;a)
  nmol/L                     1.59 (A;a)      1.49 (A;a)
Thyroxine (T4), p d/L        3.50 (A;a)      5.22 (A;a)
                             2.92 (B;a)      2.90 (A;a)
Glucose (GLU), nmol/L        6.12 (A;a)      5.66 (A;a)
                             6.08 (A;a)      6.18 (B;a)
Phosphorus (IP), mmol/L      2.61 (A;a)      2.76 (A;a)
                             3.28 (B;a)      3.39 (B;a)
Magnesium (Mg), mmol/L       0.996 (A;a)     0.932 (A;b)
                             0.960 (A;a)     0.966 (A;b)
Potassium (K)                4.65 (A;a)      5.69 (A;b)
                             4.96 (A;a)      4.74 (B;a)
Sodium (Na)                  144.0 (A;a)     142.0 (A;b)
                             146.6 (B;a)     144.4 (A;a)
Iron (Fe), pmol/L            31.5 (A;a)      23.5 (A;b)
                             47.1 (A;a)      51.4 (B;a)
Calcium (Ca), nmol/L         2.71 (A;a)      2.55 (A;a)
                             2.79 (A;a)      2.78 (B;a)
Vitamin B12, pmol/L          78.2 (A;a)      131.0 (A;b)
                             94.2 (A;a)      98.2 (B;a)
Creatinine (CREA), pmol/L    78.8 (A;a)      63.4 (A;a)
                             48.2 (B;a)      49.4 (A;a)
Alkaline phosphatase (AP),   408.6 (A;a)     318.0 (A;a)
  U/L                        242.6 (B;a)     245.4 (A;a)
Urea, mmol/L                 2.64 (A;a)      2.58 (A;a)
                             3.19 (B;a)      2.63 (B;a)
Thyroid-stimulating          0.0208 (A;a)    0.0236 (A;a)
  hormone (TSH)              0.0230 (A;a)    0.0260 (B;a)
Total bilirubin (pmol/L)     1.99 (A;a)      1.99 (A;a)
                             1.99 (A;a)      2.65 (A;b)

[S.sub.nonV]--non-vaccinated piglets fed with control group compound
feed; [S.sub.V]--vaccinated piglets fed with control group compound
feed; [RF.sub.nonV]--non-vaccinated piglets fed with fermented
compound feed; [RF.sub.V]--vaccinated piglets fed with fermented
compound feed. Measurements were made at baseline-day 25, before the
start of the feeding experiment-and on day 61, the end of the
experiment. (A,B) Different uppercase letters indicate significant
treatment duration-related differences (p [less than or equal to]
0.05). (a,b) Different lowercase letters indicate differences among
treatments: [S.sub.nonV] and [S.sub.V]; [RF.sub.nonV] and [RF.sub.V]
(p [less than or equal to] 0.05). Data are presented as mean values
(n = 10 per group).

Table 4. Tests of between-subject effects: influence of the analysed
factors and their interaction on piglets' blood parameters.

Dependent VariableTD       FF      V       TD x FF   TD x V   FF x V

Significance (p)

AST, U/L          0.279    0.025   0.191   0.182     0.404    0.598
ALT, U/L          0.0001   0.017   0.557   0.997     0.358    0.453
Choi, mmol/L      0.004    0.088   0.608   0.467     0.907    0.809
HDL-C, mmol/L     0.069    0.123   0.768   0.501     0.905    0.185
LDL-C, mmol/L     0.045    0.723   0.807   0.143     0.584    0.760
TG, mmol/L        0.002    0.018   0.382   0.206     0.591    0.459
TRg/L             0.0001   0.155   0.773   0.345     0.811    0.310
ALB, g/L          0.002    0.581   0.693   0.061     0.937    0.529
IgGg/L            0.112    0.699   0.329   0.612     0.660    0.299
T3, nmol/L        0.001    0.120   0.522   0.038     0.909    0.994
T4, p d/L         0.003    0.004   0.331   0.041     0.008    0.033
GLU, nmol/L       0.633    0.716   0.660   0.458     0.300    0.633
IP, mmol/L        0.001    0.179   0.878   0.658     0.851    0.349
Mg, mmol/L        0.675    0.487   0.060   0.655     0.867    0.250
K                 0.885    0.041   0.203   0.153     0.007    0.462
Na                0.0001   0.548   0.039   0.108     0.464    0.548
Fe, pmol/L        0.001    0.001   0.694   0.008     0.370    0.830
Ca, nmol/L        0.001    0.985   0.176   0.379     0.657    0.816
B12, pmol/L       0.158    0.008   0.158   0.055     0.121    0.003
CREA, pmol/L      0.069    0.831   0.406   0.222     0.463    0.864
AP, U/L           0.027    0.490   0.256   0.521     0.521    0.966
Urea, mmol/L      0.164    0.797   0.899   0.286     0.075    0.014
TSH               0.604    0.523   0.736   0.854     0.951    0.854
Total bilirubin   0.338    0.280   0.280   0.290     0.290    0.349
  (pmol/L)

Dependent VariableTD x FF
                  x V

Significance (p)

AST, U/L          0.791
ALT, U/L          0.481
Choi, mmol/L      0.396
HDL-C, mmol/L     0.482
LDL-C, mmol/L     0.149
TG, mmol/L        0.688
TRg/L             0.041
ALB, g/L          0.276
IgGg/L            0.442
T3, nmol/L        0.949
T4, p d/L         0.685
GLU, nmol/L       0.745
IP, mmol/L        0.993
Mg, mmol/L        0.422
K                 0.902
Na                0.388
Fe, pmol/L        0.267
Ca, nmol/L        0.313
B12, pmol/L       0.934
CREA, pmol/L      0.660
AP, U/L           0.588
Urea, mmol/L      0.456
TSH               0.691
Total bilirubin   0.338
  (pmol/L)

AST--Aspartate aminotransferase, ALT--Alanine aminotransferase,
Choi--Cholesterol, HDL-C--High-density lipoprotein cholesterol,
LDL-C--Low-density lipoprotein cholesterol, TG--Triglycerides,
TP--Total protein, ALB--Albumin, T3--Triiodothyronine, T4--Thyroxine,
GLU--Glucose, IP--Phosphorus, Mg--Magnesium, K--Potassium,
Na--Sodium, Fe--Iron, Ca--Calcium, CREA--Creatinine, AP--Alkaline
phosphatase, TSH--Thyroid-stimulating hormone. TD--treatment
duration, FF--fermented feed, V--vaccination. Bold values indicate
significant differences (p [less than or equal to] 0.05).

Table 5. Influence of the analysed factors and their interactions on
piglets' growth performance.

Piglets Growth
Performance          Average from     [S.sub.nonV]
FCR                  day 25 to 61     1.56
ADG                                   0.395

Tests of between-subjects effects: influence of analysed factors and
their interactions on FCR and ADG
Dependent Variable   Fermented Feed   Vaccination

Significance (p)

FCR                  0.154                           1.000
ADG                  0.962                           0.996

Differences among treatments (p < 0.05)

SyVS.Snonv           [RF.sub.V] vs    [S.sub.V] vs   [S.sub.nonV] vs
                     [RF.sub.nonV]    [RF.sub.V]     [RF.sub.nonV]
ADG

0.901                0.783            0.55

FCR

0.001                0.002            0.0001

Piglets Growth       Treatments
Performance          [S.sub.V]    [RF.sub.nonV]     [RF.sub.V]
FCR                  1.38         1.58              1.76
ADG                  0.392        0.397             0.399

Tests of between-subjects effects: influence of analysed factors and
their interactions on FCR and ADG
Dependent Variable                Fermented Feed
                                  x Vaccination
Significance (p)

FCR                                                 0.194
ADG                                                 0.979

Differences among treatments (p < 0.05)

SyVS.Snonv                        [S.sub.nonV] vs   [RF.sub.nonV] vs
                                  [RF.sub.V]        [S.sub.V]
ADG

0.901                0.943        0.91              0.286

FCR

0.001                0.773        0.91              0.074

[S.sub.n0n]V--non-vaccinated piglets fed with control group compound
feed; [S.sub.v]--vaccinated piglets fed with control group compound
feed; [RF.sub.non]v--non-vaccinated piglets fed with fermented
compound feed; [RF.sub.v]--vaccinated piglets fed with fermented
compound feed. FCR--feed conversion ratio; ADG--average daily gain.
Measurements were made at baseline--on day 25, before the start of
the feeding experiment--and on day 61, the end of the experiment.
Bold values indicate significant differences (p [less than or equal
to] 0.05). Data are presented as mean values (n = 100 per group).

Table 6. Influence of the analysed factors on ammonia emission.

Ammonia                 [S.sub.nonV]   [S.sub.y]

Emission    Baseline    0.837 (A;a)    1.172 (A;b)
            61          1.938 (B;a)    1.063 (A;b)

Tests of be tween-subject effects: influence of the analysed factors
and their interactions on ammonia emission
Treatment   Fermented   Vaccination    Treatment Vaccination
Duration    Feed                       Duration x
                                       Fermented Feed

                        Significance (p)

0.0001      0.003       0.0001         0.0001

            Treatments
Ammonia     [RF.sub.non]V                         RFy

Emission    1.584 (A;a)                           1.252 (A;b)
            1.538 (A;a)                           0.810 (B;b)

Tests of be tween-subject effects: influence of the analysed factors
and their interactions on ammonia emission
Treatment   Treatment Duration   Fermented Feed   Treatment Duration
Duration    x Vaccination        x Vaccination    x Fermented Feed
                                                  x Vaccination

0.0001      0.0001               0.0001           0.0001

[S.sub.n0n]V--non-vaccinated piglets fed with soya meal;
[S.sub.v]--vaccinated piglets fed with soya meal;
[RF.sub.non]V--non-vaccinated piglets fed with fermented rapeseed
meal; [RF.sub.v]--vaccinated piglets fed with fermented rapeseed
meal. Measurements were done at baseline, on day 25 before the start
of the feeding experiment, and on day 61, the end of the experiment.
(A,B) Different uppercase letters indicate significant treatment
duration-related differences (p [less than or equal to] 0.05). (a,b)
Different lowercase letters indicate differences among treatments (p
[less than or equal to] 0.05). Bold values indicate significant
differences [p [less than or equal to] 0.05). Data are presented as
the mean values (n = 3).

Figure 3. Microbial profiles (prevalence, %) at the genus level in
pig faeces after experiment.

                   RFnonV   RFV    SnonV   SV

Prevotella         31.4     30.2   51.4    29.1
Lactobacillus      33.3     47.9   7.2     17.5
Clostridium        0.3      0.6    9.6     3.4
Anaerovibrio       1        0.4    2.8     0.8
Terrisporobacter   0.1      0.5    4.1     2
Faecalibacterium   2.8      1.4    2.8     3.5
Gemmiger           1.6      0.6    2.3     2.3
Alloprevotella     1.2      0.9    1.4     0.6
Eubacterium        0.9      0.9    1.1     0.8
Blautia            1.3      0.8    1.1     0.8
Roseburia          0.8      0.7    1.1     1.2
Megasphaera        3        1.6    0.8     3
Collinsella        2.4      0.1    0.1     2.8
Barnesiella        1.7      0.9    0.7     4.9
Olsenella          0.9      0      0.1     2.9
Denitrobacterium   0.9      0      0.04    1.3
Oscillospira       0.5      0.2    0.2     1.2
Oscillibacter      0.3      0.2    0.1     1
COPYRIGHT 2020 MDPI AG
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2020 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Vadopalas, Laurynas; Badaras, Sarunas; Ruzauskas, Modestas; Lele, Vita; Starkute, Vytaute; Zavistana
Publication:Animals (Basel)
Geographic Code:1U9CA
Date:Jul 1, 2020
Words:12906
Previous Article:Breeding and Economic Aspects of Cytogenetic Screening Studies of Pigs Qualified for Reproduction.
Next Article:Identifying Barriers to Implementing Pain Management for Piglet Castration: A Focus Group of Swine Veterinarians.
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |